|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D12.5 |
Benign neoplasm of sigmoid colon
|
D125 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 10.03%
|
30.60%
|
26.25%
|
16.49%
|
8.34%
|
3.87%
|
1.82%
|
0.96%
|
0.61%
|
0.31%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D12.5*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
16,924
|
31,958
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
10,113
|
352,632
|
|
45385
|
COLONOSCOPY W/LESION REMOVAL |
9,190
|
9,189
|
|
45380
|
COLONOSCOPY AND BIOPSY |
6,478
|
6,478
|
|
J7120
|
RINGERS LACTATE INFUSION |
3,282
|
3,692
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
2,967
|
12,472
|
|
43239
|
EGD BIOPSY SINGLE/MULTIPLE |
2,882
|
2,881
|
|
J3010
|
FENTANYL CITRATE INJECTION |
2,644
|
4,140
|
|
J2001
|
LIDOCAINE INJECTION |
1,875
|
15,879
|
|
J7030
|
NORMAL SALINE SOLUTION INFUS |
1,472
|
1,645
|
|
82962
|
GLUCOSE BLOOD TEST |
1,282
|
1,400
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
1,092
|
4,314
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
1,082
|
1,276
|
|
G0500
|
MOD SEDAT ENDO SERVICE >5YRS |
1,020
|
1,020
|
|
J2405
|
ONDANSETRON HCL INJECTION |
855
|
3,490
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
808
|
813
|
|
45381
|
COLONOSCOPY SUBMUCOUS NJX |
785
|
784
|
|
99153
|
MOD SED SAME PHYS/QHP EA |
775
|
1,208
|
|
U0003
|
COV-19 AMP PRB HGH THRUPUT |
725
|
725
|
|
00811
|
ANES LWR INTST NDSC NOS |
683
|
9,707
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D12.5 related to the following DRG Codes:
393-395
|
